Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

April 26, 2015 9:23 AM ET


Company Overview of Aragon Pharmaceuticals, Inc.

Company Overview

Aragon Pharmaceuticals, Inc. develops medicines for the treatment of hormonally-driven cancers such as prostate and breast cancer. It develops ARN-509, a compound for the treatment of castration-resistant prostate cancer. It also develops selective androgen receptor degraders and selective estrogen receptor degraders that prevent cancer growth by inhibiting hormone action on the receptor and inducing receptor degradation; and ARN-810, an oral selective estrogen receptor degrader for the treatment of locally advanced or metastatic estrogen receptor positive breast cancer in post-menopausal women. The company was founded in 2009 and is based in San Diego, California. As of August 19, 2013, Ara...

12780 El Camino Real

Suite 301

San Diego, CA 92130

United States

Founded in 2009





Key Executives for Aragon Pharmaceuticals, Inc.

Co-Founder and Scientific Advisor
Age: 55
Chief Medical Officer
Age: 52
Vice President of Finance
Age: 41
Compensation as of Fiscal Year 2014.

Aragon Pharmaceuticals, Inc. Key Developments

Aragon Pharmaceuticals, Inc. Presents at Jefferies 2013 Global Healthcare Conference, Jun-05-2013 08:00 AM

Aragon Pharmaceuticals, Inc. Presents at Jefferies 2013 Global Healthcare Conference, Jun-05-2013 08:00 AM. Venue: Grand Hyatt Hotel, 109 East 42nd Street at Grand Central, New York, New York, United States. Speakers: Paul B. Cleveland, Chief Financial Officer and Executive Vice President of Corporate Strategy.

Similar Private Companies By Industry

Company Name Region
Ives Formulation Company, Inc. United States
Amedra Pharmaceuticals LLC United States
Arsanis, Inc. United States
Nutraquest, Inc. United States
AlphaMed Pharmaceuticals Corporation United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Aragon Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at